Dare Bioscience SG&A Expense (Quarterly) Insights

Dare Bioscience Inc (DARE)

0.4133 -0.02 (-4.02%) USD | NASDAQ | May 31, 16:00

0.41 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
March 31, 2024	2.703M
December 31, 2023	3.080M
September 30, 2023	2.722M
June 30, 2023	2.946M
March 31, 2023	3.362M
December 31, 2022	3.154M
September 30, 2022	2.676M
June 30, 2022	2.818M
March 31, 2022	2.57M
December 31, 2021	2.427M
September 30, 2021	2.236M
June 30, 2021	1.823M
March 31, 2021	1.965M
December 31, 2020	1.802M
September 30, 2020	1.378M
June 30, 2020	1.578M
March 31, 2020	1.874M
December 31, 2019	1.487M
September 30, 2019	1.452M
June 30, 2019	1.470M
March 31, 2019	1.390M
December 31, 2018	1.295M
September 30, 2018	1.175M

Date	Value
June 30, 2018	1.407M
March 31, 2018	1.303M
December 31, 2017	0.9755M
September 30, 2017	1.053M
June 30, 2017	0.476M
March 31, 2017	0.2007M
December 31, 2016	-0.2114M
September 30, 2016	0.006M
June 30, 2016	2.773M
March 31, 2016	3.118M
December 31, 2015	2.872M
September 30, 2015	2.954M
June 30, 2015	2.717M
March 31, 2015	2.681M
December 31, 2014	2.607M
September 30, 2014	2.441M
June 30, 2014	2.029M
March 31, 2014	1.51M
December 31, 2013	1.575M
September 30, 2013	1.227M
June 30, 2013	1.392M
March 31, 2013	1.972M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.378M

Minimum

Sep 2020

3.362M

Maximum

Mar 2023

2.276M

Average

2.332M

Median

SG&A Expense (Quarterly) Benchmarks